BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32037692)

  • 1. Management of children and adolescents with gray zone lymphoma: A case series.
    Perwein T; Lackner H; Ebetsberger-Dachs G; Beham-Schmid C; Zach K; Tamesberger M; Simonitsch-Klupp I; Lüftinger R; Dworzak M; Mann G; Benesch M; Attarbaschi A;
    Pediatr Blood Cancer; 2020 May; 67(5):e28206. PubMed ID: 32037692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray Zone Lymphoma: Current Diagnosis and Treatment Options.
    Pilichowska M; Kritharis A; Evens AM
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1251-1260. PubMed ID: 27888879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.
    Tanaka Y; Maeshima AM; Nomoto J; Makita S; Fukuhara S; Munakata W; Maruyama D; Tobinai K; Kobayashi Y
    Eur J Haematol; 2018 May; 100(5):511-517. PubMed ID: 29377256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
    Tao Y; Chen H; Liu D; Dai X
    Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How I manage patients with grey zone lymphoma.
    Kritharis A; Pilichowska M; Evens AM
    Br J Haematol; 2016 Aug; 174(3):345-50. PubMed ID: 27301470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
    Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
    Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA.
    Sarkozy C; Copie-Bergman C; Damotte D; Ben-Neriah S; Burroni B; Cornillon J; Lemal R; Golfier C; Fabiani B; Chassagne-Clément C; Parrens M; Herbaux C; Xerri L; Bossard C; Laurent C; Cheminant M; Cartron G; Cabecadas J; Molina T; Salles G; Steidl C; Ghesquières H; Mottok A; Traverse-Glehen A
    Am J Surg Pathol; 2019 Mar; 43(3):341-351. PubMed ID: 30540571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term complete remission following tandem autologous stem cell transplantation and consolidative radiotherapy for refractory mediastinal gray-zone lymphoma.
    Takaishi K; Muto T; Mimura N; Takiguchi J; Nagao Y; Oshima-Hasegawa N; Tsukamoto S; Takeda Y; Mitsukawa S; Takeuchi M; Ohwada C; Ota S; Iseki T; Nakaseko C; Sakaida E
    Int J Hematol; 2018 Oct; 108(4):452-455. PubMed ID: 29786758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and pathological characteristics and prognosis analysis of gray zone lymphoma].
    Liu SZ; Zong XP; Cai WZ; He HJ; Ma ZX; Li JQ; Li CX; Wu DP
    Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):69-73. PubMed ID: 38178771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
    Gibson SE; Dojcinov S; Dotlic S; Hartmann S; Hsi ED; Klimkowska M; Melle F; Pileri SA; Ramsower CA; Rech K; Rimsza LM; Rodriguez-Pinilla SM; Tousseyn TA; de Jong D; Sabattini E
    Virchows Arch; 2023 Dec; 483(6):733-749. PubMed ID: 37530791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?
    Grant C; Dunleavy K; Eberle FC; Pittaluga S; Wilson WH; Jaffe ES
    Curr Hematol Malig Rep; 2011 Sep; 6(3):157-63. PubMed ID: 21590365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of gray zone lymphoma.
    Sarkozy C; Chong L; Takata K; Chavez EA; Miyata-Takata T; Duns G; Telenius A; Boyle M; Slack GW; Laurent C; Farinha P; Molina TJ; Copie-Bergman C; Damotte D; Salles GA; Mottok A; Savage KJ; Scott DW; Traverse-Glehen A; Steidl C
    Blood Adv; 2020 Jun; 4(11):2523-2535. PubMed ID: 32516416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray-zone lymphoma. Examples of rare clinical manifestation.
    Misyurina AE; Kravchenko SK; Mangasarova YK; Magomedova AU; Kovrigina AM; Shimanovskaya LT; Fastova EA; Misyurin VA; Model SV; Chebotarev DI; Kostina IE; Savchenko VG
    Ter Arkh; 2019 May; 91(4):107-113. PubMed ID: 31094484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gray zone lymphoma: five cases report and literature review].
    Zou HS; Zhang HJ; Liu HM; Huang WY; Liu W; Lyu R; Wang TY; Sui WW; Fu MW; Wang Q; Qiu LG; Zou DH
    Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):242-246. PubMed ID: 37356987
    [No Abstract]   [Full Text] [Related]  

  • 15. Brentuximab vedotin maintenance after autologous stem cell transplantation for refractory gray zone lymphoma with long-term remission.
    Terao T; Yuda J; Yamauchi N; Guo YM; Shimada K; Sugano M; Ishii G; Minami Y
    Mol Clin Oncol; 2021 Jun; 14(6):125. PubMed ID: 33936598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
    Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
    Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational landscape of gray zone lymphoma.
    Sarkozy C; Hung SS; Chavez EA; Duns G; Takata K; Chong LC; Aoki T; Jiang A; Miyata-Takata T; Telenius A; Slack GW; Molina TJ; Ben-Neriah S; Farinha P; Dartigues P; Damotte D; Mottok A; Salles GA; Casasnovas RO; Savage KJ; Laurent C; Scott DW; Traverse-Glehen A; Steidl C
    Blood; 2021 Apr; 137(13):1765-1776. PubMed ID: 32961552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.
    Sarkozy C; Molina T; Ghesquières H; Michallet AS; Dupuis J; Damotte D; Morsschauser F; Parrens M; Martin L; Dartigues P; Stamatoullas A; Hirsch P; Fabiani B; Bouabdallah K; da Silva MG; Maerevoet M; Laurent C; Coiffier B; Salles G; Traverse-Glehen A
    Haematologica; 2017 Jan; 102(1):150-159. PubMed ID: 27758822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
    Evens AM; Kanakry JA; Sehn LH; Kritharis A; Feldman T; Kroll A; Gascoyne RD; Abramson JS; Petrich AM; Hernandez-Ilizaliturri FJ; Al-Mansour Z; Adeimy C; Hemminger J; Bartlett NL; Mato A; Caimi PF; Advani RH; Klein AK; Nabhan C; Smith SM; Fabregas JC; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA
    Am J Hematol; 2015 Sep; 90(9):778-83. PubMed ID: 26044261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation.
    Liu X; Deng T; Guo X; Guo Y; Wang L; Zhang J; Xia Z; Zhang Q; Xue K; Cao J; Shi J; Hong X
    Hematology; 2017 Jun; 22(5):258-264. PubMed ID: 27884092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.